Find in Library
Search millions of books, articles, and more
Indexed Open Access Databases
Accuracy of intraoperative aberrometry versus preoperative biometry for intraocular lens power selection in short and long eyes
oleh: Pedro Tañá-Rivero, Paz Orts-Vila, Pedro Tañá-Sanz, Santiago Tañá-Sanz, Ramón Ruiz-Mesa, Robert Montés-Micó
Format: | Article |
---|---|
Diterbitkan: | Frontiers Media S.A. 2024-10-01 |
Deskripsi
BackgroundTo compare the accuracy of intraoperative wavefront aberrometry using the ORA VLynk system with different biometry-based formulas in short and long eyes after cataract surgery.MethodsThis prospective study considered 48 eyes with axial lengths of <22.1 mm and 48 eyes with axial lengths of >25.0 mm. All eyes were implanted with the monofocal AcrySof IQ IOL, the power being determined using the ORA VLynk. The postoperative spherical equivalent (SE) at 3 months was compared to that predicted preoperatively using the SRK/T, Hoffer Q, Haigis, Holladay 2, Barrett Universal II, and Barrett True K formulas and intraoperatively using the ORA VLynk. Mean numerical and absolute errors and the percentage of eyes within ±0.50 D/1.00 D of their target were obtained.ResultsFor long eyes, the mean absolute error values were 0.35, 0.52, 0.34, 0.30, 0.29, 0.27, and 0.24D for SRK/T, Hoffer Q, Haigis, Holladay 2, Barrett Universal II, Barrett True K, and ORA VLynk, respectively (p < 0.001). These values were 0.55, 0.45, 0.49, 0.40, 0.44, 0.44 and 0.50 D for short eyes, respectively (p < 0.001). The proportions of long eyes within ±0.50 D of the target were 77.08, 50, 75, 85.42, 83.33, 79.17, and 87.50%, respectively; and 50, 66.67, 60.42, 66.67, 60.42, 60.42, and 58.33%, respectively, for short eyes.ConclusionThe ORA VLynk performs better than all biometry-based formulas in long eyes and, in short eyes, it is as effective as SRK/T, Haigis, Barrett Universal II, and Barrett true K, with the Hoffer Q and Holladay 2 being the most accurate; however, the differences between the calculation methods were small.Clinical trial registrationIdentifier DRKS000028106.